Systemic and Specific Delivery of Small Interfering RNAs to the Liver Mediated by Apolipoprotein A-I
Open Access
- 1 June 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (6) , 1145-1152
- https://doi.org/10.1038/sj.mt.6300168
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- RNAi-mediated gene silencing in non-human primatesNature, 2006
- AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damageGene Therapy, 2006
- Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA DeliveryCancer Research, 2005
- Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsNature Biotechnology, 2005
- Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptorsNature Biotechnology, 2005
- RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivoGene Therapy, 2004
- Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAsNature, 2004
- Gene Silencing by Systemic Delivery of Synthetic siRNAs in Adult MiceJournal of Molecular Biology, 2003
- RNA interferenceNature, 2002
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature, 2001